Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases

Marta Chierichetti1, Mauro Cerretani2, Alina Ciammaichella3

  • 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.

Life Sciences
|December 27, 2022
PubMed
Abstract

Insights

Researchers identified novel compounds that enhance HSPB8 protein activity, crucial for clearing misfolded proteins in neurodegenerative diseases. These findings offer potential therapeutic strategies for conditions involving protein aggregation.

Area of Science:

  • Cellular Biology
  • Neuroscience
  • Drug Discovery

Background:

  • The Chaperone-Assisted Selective Autophagy (CASA) complex, with HSPB8 as its core, is vital for clearing misfolded proteins and maintaining proteostasis.
  • HSPB8 protects neurons from toxicity in neurodegenerative disease models by promoting autophagy and degradation of misfolded proteins.

Purpose of the Study:

  • To identify small molecules that enhance the protective activity of HSPB8.
  • To discover compounds that increase HSPB8 gene transcription, translation, or protein stability.

Main Methods:

  • Screening of approximately 120,000 small molecules to find activators of HSPB8.
  • Assessing compound efficacy in SH-SY5Y cells for HSPB8 expression and in vitro assays for reducing protein aggregation.

Main Results:

  • Identified 83 active compounds, further classified into 19 chemical classes.
  • 14 compounds increased HSPB8 mRNA and protein levels; 3 of these reduced misfolded SOD1 aggregation and enhanced autophagy receptor expression.
  • The protective effects of the 3 hit compounds were dependent on the presence of HSPB8.

Conclusions:

  • The identified compounds show therapeutic potential for neurodegenerative diseases and other disorders characterized by protein misfolding.
  • Enhancing CASA complex activity through these compounds may offer a novel treatment strategy.